BRIEF-Valeant CEO Pearson to give deposition to U.S. Senate drug pricing committee - Bloomberg

Wed Apr 13, 2016 9:23am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

April 13 (Reuters) -

* Valeant Pharmaceuticals CEO Mike Pearson will give deposition to U.S Senate committee investigating drug pricing, avoiding contempt - Bloomberg

Source - (bloom.bg/1qHMFy9)

Further company coverage: (Reporting by Vishal Sridhar)